Top Markets
#1 Black Phoenix Black Phoenix +826.33%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.37%
#3 Beam Beam +24.59%
#4 Tutorial Tutorial +24.41%
#5 SAFEcoin SAFEcoin +20.66%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +19.16%
#7 Bless Bless +18.37%
#8 Magma Finance Magma Finance +17.12%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +15.35%
#10 THORChain THORChain +15.06%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Pharvaris N.V. Pharvaris N.V.

Pharvaris N.V.

PHVS
Rang in aandelen #5629
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the... Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Aandeelprijs
$36.71
Marktkapitalisatie
$2.57B
Verandering (1 dag)
-0.79%
Verandering (1 jaar)
54.36%
Land
NL
Handel Pharvaris N.V. (PHVS)

Categorie

Healthcare
P/B-ratio voor Pharvaris N.V. (PHVS)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Pharvaris N.V. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Pharvaris N.V. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH